QYUNS-B(02509): The China Securities Regulatory Commission has issued a notice letter regarding the filing for the full circulation of H shares of the company.
China Resources Biotech-B (02509) announces that the company has received notification from the China Securities Regulatory Commission that the date of issuance for the application is in 2025...
QYUNS-B (02509) announced that the company has received a record notification letter from the China Securities Regulatory Commission dated January 20, 2025 for the application. According to the record notification letter, the 17.3224 million domestic shares issued by the company have been converted into H shares and listed on the Stock Exchange of Hong Kong. If the share conversion is not completed within 12 months from the date of the record notification letter, the company must update the record materials to the China Securities Regulatory Commission for further approval.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


